The RESP Sensor from Strados labs received FDA clearance for early, remote detection of lung acoustic and ventilation pattern changes to predict worsening respiratory disease.
Lung sounds associated with asthma, COPD, heart failure and infectious diseases including COVID-19 are detected.
Frequency of wheezing, coughing, shortness of breath, and respiratory dynamics including rate and excursion are collected and anlyzed using a noninvasive chest sensor and cloud platform.
Individuals can monitor themselves at home, and the data can be integrated into telehealth, tele ICU, clinical trial management platforms and telemetry systems.